Posts With Tag IDEXX Laboratories

IDEXX Laboratories, Inc. reports Q1 2025 revenues of $998.4M, up 3.5%. With rising EPS and solid growth in the Companion Animal Group, this stock is a strong buy for investors.

Discover IDEXX Laboratories Inc.'s latest 8-K filing from May 1, 2025, detailing stock metrics and financial insights impacting shareholders. Stay informed on IDXX.

Explore IDEXX Laboratories Inc.'s latest 8-K filing from February 13, 2025, highlighting crucial investor updates and significant events impacting stock performance.